Parker R B, Laizure S C, Williams C L, Mandrell T D, Lima J J
Department of Clinical Pharmacy, The University of Tennessee, Memphis, 38163, USA.
Life Sci. 1998;62(4):333-42. doi: 10.1016/s0024-3205(97)01115-6.
Cocaine use continues to be widespread in the United States. Most cocaine users co-ingest ethanol resulting in decreased elimination of cocaine and formation of the active cocaine metabolite, cocaethylene, by hepatic carboxylesterases. In a recent study from our laboratory in dogs to evaluate the cocaine-ethanol interaction, we demonstrated a similar ethanol-induced reduction in cocaine metabolism, although we were unable to detect cocaethylene when the two drugs were given together. This unexpected finding could be explained by ethanol-induced inhibition of cocaine metabolism via a pathway that does not involve hepatic carboxylesterases or formation of cocaethylene that inhibits cocaine metabolism and is then rapidly cleared. The purpose of the present study is to determine which of these mechanisms best explain our data by characterizing the pharmacokinetics of cocaine and cocaethylene over a range of doses in conscious dogs. Seven adult mongrel dogs received 1, 3, and 5 mg/kg cocaine and cocaethylene HCl base with each drug dose administered i.v. on a separate study day. Arterial blood samples were collected at various times after each dose and analyzed for cocaine and cocaethylene by HPLC. Cocaine clearance was dose-dependent with clearance decreasing from 1.53 +/- 0.31 to 1.09 +/- 0.11 l/min as the dose was increased from 1 to 5 mg/kg (p<0.05). Vmax x Vss and Km for cocaine were 0.95 +/- 0.40 l/min/kg and 11.2 +/- 6.2 mg/kg, respectively. Cocaethylene pharmacokinetics were similar to those of cocaine, but were not dose-dependent over the dose range of 1-5 mg/kg. These results suggest that cocaethylene is not formed and rapidly cleared after co-administration of cocaine and ethanol to the dog, but rather suggests that cocaethylene is not formed in appreciable quantities in the dog. Therefore, we conclude that the decrease in cocaine elimination in the dog associated with ethanol administration is due to ethanol-mediated inhibition cocaine metabolism, rather than inhibition by cocaethylene.
在美国,可卡因的使用仍然广泛存在。大多数可卡因使用者同时摄入乙醇,这导致可卡因的消除减少,并通过肝脏羧酸酯酶形成活性可卡因代谢物——可口乙酮。在我们实验室最近一项关于评估可卡因 - 乙醇相互作用的犬类研究中,我们证明了乙醇对可卡因代谢有类似的降低作用,尽管当两种药物一起给药时我们无法检测到可口乙酮。这一意外发现可以通过乙醇通过不涉及肝脏羧酸酯酶的途径抑制可卡因代谢来解释,或者是通过形成抑制可卡因代谢然后迅速清除的可口乙酮来解释。本研究的目的是通过在清醒犬类中测定一系列剂量下可卡因和可口乙酮的药代动力学,确定这些机制中哪一种最能解释我们的数据。七只成年杂种犬分别在不同的研究日静脉注射接受1、3和5mg/kg的可卡因和盐酸可口乙酮碱。每次给药后在不同时间采集动脉血样,并通过高效液相色谱法分析可卡因和可口乙酮。可卡因清除率呈剂量依赖性,随着剂量从1mg/kg增加到5mg/kg,清除率从1.53±0.31降至1.09±0.11l/min(p<0.05)。可卡因的Vmax×Vss和Km分别为0.95±0.40l/min/kg和11.2±6.2mg/kg。可口乙酮的药代动力学与可卡因相似,但在1 - 5mg/kg的剂量范围内不呈剂量依赖性。这些结果表明,可卡因和乙醇共同给药给犬后,可口乙酮并未形成并迅速清除,而是表明在犬体内不会大量形成可口乙酮。因此,我们得出结论,犬类中与乙醇给药相关的可卡因消除减少是由于乙醇介导的对可卡因代谢的抑制,而不是可口乙酮的抑制作用。